Remember when Donald Trump said there would be people standing in bread lines trying to get food if Kamala Harris won? People are standing in line for food in Cleveland because of Donald Trump. It’s always pure projection.

In memory of all the journalists k!lled in GAZA GEN0CIDE 💔

How it started: Don’t be evil How it’s going: theintercept.com/2025/11/04/…

YouTube deleted all my coverage of Israeli soldiers shooting civilians, including children targeted on a live stream, along with my entire account. No community guidelines violated & 3 separate excuses given to me. Then Google deleted my email & won’t respond to appeals.

Femme that can’t keep her hands off me #Manifesting

Cuando buscas ropa de bebé pero solo encuentras sex shops. Será una señal? 🤔

In a stunning medical breakthrough, scientists in China have successfully reversed Type 1 diabetes in a female patient by using her own stem cells. For the first time since her diagnosis, her body began producing insulin naturally, eliminating the need for daily injections. This achievement could change the future of diabetes treatment forever. The innovative procedure began by collecting the woman’s own cells and reprogramming them into stem cells. Researchers then guided these stem cells to become insulin-producing beta cells. Once developed, the lab-grown cells were implanted into her abdomen. These newly introduced cells began secreting insulin, effectively regulating her blood sugar levels from within. The clinical study included three patients with Type 1 diabetes, but the woman was the first to show full insulin independence. This marks a significant step forward in regenerative medicine and offers a potential pathway toward long-term relief from this chronic autoimmune condition. Type 1 diabetes affects millions worldwide, and current treatment relies heavily on lifelong insulin therapy. This stem cell method not only reduces that dependency but also opens the door to a personalised, cell-based cure. While the research is still in early stages and requires further validation, the success of this procedure shines a hopeful light on what the future of diabetes care may look like.

This is what Israel calls a ceasefire.

🧩 What if luck isn’t just random — but follows patterns hidden in the quantum fabric of reality? Quantum physics shows the universe isn’t pure chaos. Beneath every coin flip or twist of fate lie probabilities, wave functions, and entanglements — subtle rules shaping what seems like chance. Scientists are exploring how these hidden patterns influence everything from particle behavior to cosmic order. Maybe “luck” is our human glimpse of deeper laws we don’t yet fully understand. Source: “Quantum Mechanics and the Determinism of the Universe”, Stanford Encyclopedia of Philosophy. Quantum physics shows the universe isn’t pure chaos. Quantum mechanics is probabilistic but not chaotic. Every event follows the Schrödinger equation, which determines probabilities of outcomes — not random chaos.

🧬 A New Way to Think About Cancer: Reprogramming Cells Instead of Destroying Them Scientists are exploring a bold new idea — what if, instead of killing cancer cells, we could teach them to be normal again? Recent studies in cell biology and genetics show that it might be possible to “reprogram” diseased cells by switching certain genes on or off, restoring the signals that tell a cell how to behave. This is the same science behind stem cell technology, where ordinary cells are turned back into stem-like ones that can grow into healthy tissue. In lab experiments, researchers have managed to partially reverse cancer-like behavior in some cell types — making them grow more slowly or behave more like normal cells. It’s early-stage work, but it suggests that cancer may not always need to be destroyed; sometimes, it could be guided back to health. This research is still in its infancy — not a cure yet, and not ready for patients. But it opens a fascinating new direction in medicine: healing by restoring balance inside our own cells, rather than attacking them from the outside. The message is powerful: the key to defeating disease might already be written within our DNA.

The gut–brain–circadian axis in anxiety and depression: a critical review frontiersin.org/journals/psy…

A recent study (shared below) reminded me that 𝐰𝐡𝐚𝐭 𝐦𝐚𝐤𝐞𝐬 𝐚 𝐏𝐡𝐃 𝐬𝐭𝐮𝐝𝐞𝐧𝐭 𝐡𝐚𝐩𝐩𝐲 𝐢𝐬 𝐧𝐨𝐭 𝐩𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐨𝐫 𝐬𝐭𝐢𝐩𝐞𝐧𝐝𝐬, 𝐛𝐮𝐭 𝐠𝐨𝐨𝐝 𝐬𝐮𝐩𝐞𝐫𝐯𝐢𝐬𝐢𝐨𝐧. Over the years, I have supervised 53 PhD students, and I can say with conviction that 𝘁𝗵𝗲𝗿𝗲 𝗶𝘀 𝗻𝗼 𝘀𝗶𝗻𝗴𝗹𝗲 𝘀𝘂𝗽𝗲𝗿𝘃𝗶𝘀𝗼𝗿𝘆 𝘀𝘁𝘆𝗹𝗲 that works for all. Each student is different, and every PhD journey has its ups and downs. With some students, I spent a disproportionate amount of time helping them gain confidence. With stronger ones, my role was to 𝗴𝘂𝗶𝗱𝗲 𝘁𝗵𝗲𝗺 𝘂𝗻𝘁𝗶𝗹 𝘁𝗵𝗲𝘆 𝗳𝗼𝘂𝗻𝗱 𝘁𝗵𝗲 𝗿𝗶𝗴𝗵𝘁 𝗽𝗿𝗼𝗯𝗹𝗲𝗺 𝗮𝗻𝗱 𝗯𝗲𝗰𝗮𝗺𝗲 𝘀𝗲𝗹𝗳-𝗱𝗿𝗶𝘃𝗲𝗻. 𝗘𝗺𝗽𝗮𝘁𝗵𝘆 𝗺𝗮𝘁𝘁𝗲𝗿𝘀. Unless a student gets genuinely interested in what he or she is doing, great work rarely happens. A good 𝘀𝘂𝗽𝗲𝗿𝘃𝗶𝘀𝗼𝗿 𝗺𝘂𝘀𝘁 𝗮𝗹𝘀𝗼 𝗵𝗮𝘃𝗲 𝗴𝗼𝗼𝗱 𝗿𝗲𝗹𝗮𝘁𝗶𝗼𝗻𝘀𝗵𝗶𝗽𝘀 𝘄𝗶𝘁𝗵 𝗰𝗼𝗹𝗹𝗲𝗮𝗴𝘂𝗲𝘀. I never restricted my students from seeking advice from other faculty. In fact, I always encouraged it and built a network they could freely approach. I also followed an 𝗼𝗽𝗲𝗻-𝗱𝗼𝗼𝗿 𝗽𝗼𝗹𝗶𝗰𝘆 - any student could walk into my office anytime for advice. I never had a lab of my own in any institution I worked at. Instead, I built common labs, shared by all, to promote collaboration and collective ownership. I have always believed that the 𝗯𝗲𝘀𝘁 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝘀 𝗮𝗿𝗲 𝘁𝗵𝗼𝘀𝗲 𝘄𝗵𝗲𝗿𝗲 𝗽𝗲𝗼𝗽𝗹𝗲 𝗮𝗻𝗱 𝗳𝗮𝗰𝗶𝗹𝗶𝘁𝗶𝗲𝘀 𝗮𝗿𝗲 𝘀𝗵𝗮𝗿𝗲𝗱, 𝗻𝗼𝘁 𝗼𝘄𝗻𝗲𝗱. I have always taken 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗳𝗼𝗿 𝗲𝗻𝘀𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗮𝘁 𝗺𝘆 𝗣𝗵𝗗 𝘀𝘁𝘂𝗱𝗲𝗻𝘁𝘀 𝗳𝗶𝗻𝗱 𝘁𝗵𝗲𝗶𝗿 𝗳𝗶𝗿𝘀𝘁 𝗷𝗼𝗯 𝗮𝗳𝘁𝗲𝗿 𝗴𝗿𝗮𝗱𝘂𝗮𝘁𝗶𝗼𝗻. Since most of them worked on industry-supported projects, this was never a problem. Nearly 90% of my PhD students wrote their first peer-reviewed paper with me. Unlike in the US, where professors often get students with prior research experience, 𝗶𝗻 𝗜𝗻𝗱𝗶𝗮 𝘄𝗲 𝘄𝗼𝗿𝗸 𝘄𝗶𝘁𝗵 𝗿𝗮𝘄 𝘁𝗮𝗹𝗲𝗻𝘁 𝗮𝗻𝗱 𝗵𝗲𝗹𝗽 𝘀𝗵𝗮𝗽𝗲 𝘁𝗵𝗲𝗺 𝗶𝗻𝘁𝗼 𝗰𝗮𝗽𝗮𝗯𝗹𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀. Faculty in Indian institutions (at least in the institutions where I worked so far - IIT Bombay, IIT Delhi and BITS Pilani) often put in far more time and effort per student than many of our counterparts abroad. The 𝗿𝗲𝗮𝗹 𝗿𝗲𝘄𝗮𝗿𝗱 𝗰𝗼𝗺𝗲𝘀 𝗳𝗿𝗼𝗺 𝘀𝗲𝗲𝗶𝗻𝗴 𝘀𝘁𝘂𝗱𝗲𝗻𝘁𝘀 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺 𝗶𝗻𝘁𝗼 𝗰𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝘁 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀, 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗼𝗿𝘀, 𝗮𝗻𝗱 𝘁𝗲𝗮𝗰𝗵𝗲𝗿𝘀. That makes everything worthwhile.

🧬 Universal Cancer Vaccine Edge: mRNA Trial Aims to Target All Tumors Researchers have entered human trials with an mRNA-based cancer vaccine designed to work off the shelf, meaning no personalization for each patient’s tumor is required. Unlike most cancer vaccines that must be tailored to a person’s individual tumor mutations, this new approach aims to trigger a broad immune response capable of going after many types of solid tumors. In pre-clinical studies, it showed striking effects in mouse models of melanoma, brain cancers and bone cancers — especially when combined with immune-checkpoint therapies — by boosting the body’s production of type-I interferons, potent immune signals that help identify and destroy tumor cells. Now, phase 1 (and early phase) human trials are underway. For example, the UK trial of the candidate vaccine coded mRNA-4359 is being tested in patients with advanced solid tumours, including melanoma and lung cancer. While still early and not yet proven to work across all cancers, this development gives hope that one day we might have a “universal” cancer vaccine that doesn’t require custom-making for each patient’s unique tumor.

“ethical billionaires”

🧠 Scientists Say Alzheimer’s May Be an Autoimmune Disease — Not a Brain Disease A bold new theory is reshaping our understanding of Alzheimer’s disease: rather than being driven by degenerating brain cells, it may stem from the brain’s own immune system turning against itself. Dr. Donald Weaver at the Krembil Brain Institute proposes that the infamous protein beta‑amyloid isn’t just a harmful byproduct—but a normal immune molecule designed to protect the brain. Under his model, beta-amyloid responds to threats like infection or injury, but because neurons and bacteria share similar fatty membranes, the immune system may begin mistaking brain cells for invaders. Over time this misfiring immune response could become chronic, triggering the cognitive decline and memory loss we associate with Alzheimer’s. This insight offers a potential explanation for why decades of anti-beta-amyloid drugs have repeatedly failed: they’re treating the symptom, not the root cause. Weaver and colleagues argue that what we need are therapies aimed at calming the brain’s immune system, not simply removing plaque. It’s a shift that could redefine how we approach prevention and treatment—and may explain how Alzheimer’s is, at its core, a kind of autoimmune disorder where the brain wages war on itself.

The Grammys will announce nominations next week. Following Beyoncé’s historic win as the first Black woman to win Best Country Album, the category has been retired and split into two: Best Contemporary Country Album (Black dominated) and Best Traditional Country Album (white dominated).

When I saw this video, it brought tears to my eyes Seeing how these young people are risking their lives for the benefit of multinational tech companies. What if we told you that the Apple store was at the bottom of this pit,would you be willing to go and pick up your iPhone 17 .

💪🏼ORGULLO MEXICANO 🇲🇽 El Virus del Papiloma Humano es una enfermedad sumamente contagiosa. Existen más de 200 tipos de este, aunque no todos son peligrosos. En promedio, cualquier persona que haya iniciado su vida sexual se contagiará de un tipo de VPH en algún momento de su vida. Eva Ramón Gallegos es una científica originaria de San Juan Bautista Tuxtepec, Oaxaca. Y ha hecho historia al ser la primera en erradicar al 100% el VPH en 29 mujeres. Es especialista en nanobiotecnología y ciencias biomédicas, lo que la ayudó a descubrir una posible solución contra el virus del papiloma humano.😱🤯 Entre sus estudios, descubrió que algunas mujeres producen en mayor medida un compuesto orgánico, lo que ayuda al tratamiento.

Just out - our major review piece @ImmunityCP , summarizing couple of decades of the research on human immune aging and providing highlights of the latest advances in the field. Led by Marina Terekhova, truly encyclopedic depth (327 references) sciencedirect.com/science/ar…